GET DAILY SIGNALSCerebras Systems (CBRS) Drops -54% Over 30 Days: Margin Pressures and What Comes Next
Key Takeaways
- Cerebras Systems (CBRS) has fallen roughly 54% over the last 30 days, with the latest close near $81.71, down from about $177.10 in early October 2026.
- The decline extends a broader pullback: shares are down approximately 61% over the last quarter after peaking near their post-IPO high of $386.34 earlier in 2026.
- Investor concerns center on declining gross margin guidance, execution risk around cloud capacity expansion, and heavy customer concentration despite fast-growing revenue.
- Demand fundamentals remain strong: the company holds a multi-year agreement with OpenAI worth more than $20 billion and reported roughly $25 billion in remaining performance obligations.
- Competition from established AI chipmakers, insider lock-up expirations, and a premium valuation have all contributed to selling pressure.
Cerebras Systems (CBRS) Company Overview and Market Position
Cerebras Systems is an artificial intelligence infrastructure company that designs and manufactures a proprietary AI compute platform delivered in racks for deployment in data centers at up to supercomputer scale. Its flagship product is the Wafer-Scale Engine 3 (WSE-3), a chip roughly the size of a dinner plate that integrates about 4 trillion transistors and 900,000 AI cores on a single wafer. The company's wafer-scale architecture is designed to deliver AI inference speeds more than an order of magnitude faster than conventional GPU-based systems while avoiding reliance on supply-constrained high-bandwidth memory.
Cerebras, founded in 2015 and headquartered in Sunnyvale, California, positions itself as a challenger to GPU-based incumbents in the AI accelerator market. Its customers span hyperscalers, foundation model labs, enterprises, and sovereign AI initiatives. Investors follow the stock closely because of its high-growth AI compute exposure, its landmark OpenAI and AWS partnerships, and the competitive risks it faces against larger, better-capitalized rivals. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Cerebras Systems (CBRS) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, CBRS has lost roughly 54% of its value, sliding from a closing price near $177.10 in early October 2026 to about $81.71 in early November. The decline accelerated in the final sessions of the period, with the stock falling more than 11% in a single day as selling pressure intensified.
The last quarter has been even steeper. Around three months ago, shares traded near $211, meaning the stock has dropped approximately 61% over that span. The retreat has been broad and persistent rather than a single-event shock, reflecting a steady unwind of post-IPO enthusiasm as the market reassessed near-term profitability and execution.
What Drove CBRS Stock Price in the Last 30 Days
Several verified factors have pressured the stock. The most significant is a sharp sequential decline in gross margin guidance. In its first-quarter 2026 results, Cerebras reported revenue of $193.4 million, up 94% year over year, with an adjusted gross margin of 47%. Management subsequently guided second-quarter adjusted gross margin down to between 36% and 38%, citing the cost of temporarily renting back systems from customers while rapidly expanding cloud capacity to support its OpenAI agreement. For full-year 2026, the company expects gross margin between 38% and 41%.
That near-term margin compression, combined with tight data-center capacity and questions around the timing of AWS deployments, has kept profitability and execution risk in focus. Investor caution has also been amplified by the expiration of insider lock-up periods following the company's May 2026 initial public offering, which increased the potential supply of shares available for sale.
What Drove CBRS Stock Performance Over the Last Quarter
The quarterly decline reflects a broader shift in sentiment rather than a single catalyst. Cerebras completed its IPO in May 2026 at $185.00 per share and surged on its debut as investors rewarded its AI infrastructure story, with the stock reaching a 52-week high of $386.34. Since then, enthusiasm has faded as the market has weighed premium valuation against slowing gross margin, ongoing losses, and intense competition from established players such as NVIDIA, Advanced Micro Devices, and Intel.
Customer concentration remains a key risk. Historically, G42 and MBZUAI accounted for the vast majority of annual revenue, while OpenAI is expected to represent a substantial portion of future revenue. Any disruption to these relationships could materially affect results. The positive backdrop—a more than $20 billion OpenAI agreement with an option to expand to 2 gigawatts and roughly $25 billion in remaining performance obligations—has not been enough to offset near-term concerns.
CBRS Stock Forecast Drivers: What Investors Should Watch Next
Cerebras is scheduled to report third-quarter 2026 results in mid-November, and the release will be closely watched for updates on gross margin trajectory, cloud capacity deployment, and progress on the OpenAI and AWS partnerships. Investors should monitor whether the company can hold or improve its margin outlook as its own data centers come online, which would help offset the temporary capacity costs that have weighed on profitability.
Beyond earnings, key factors include the pace of AWS deployment timing, any changes to the OpenAI relationship, customer diversification efforts, and the competitive response from larger chipmakers. Analyst price targets remain substantially above the current share price, but near-term execution on gross margin and capacity will likely determine whether sentiment stabilizes. From what I see, this is important because near-term results will set the tone for how the market prices the longer-term growth story.
My Experience Exploring Tickeron AI Trading Bots
I have found Tickeron AI Trading Bots useful for reviewing automated strategies across various timeframes and market conditions. The platform offers a range of bots that can complement fundamental research by highlighting patterns in high-growth names like this one, giving an additional data-driven lens without replacing core analysis.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CBRS's RSI Oscillator is remaining in oversold zone for 4 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.120) is normal, around the industry mean (5.123). P/E Ratio (-17.552) is within average values for comparable stocks, (14.329). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry Semiconductors
Advertisement